ArticleInternational journal of clinical and experimental pathology2019

A high expression of MTERF3 correlates with tumor progression and predicts poor outcomes in patients with brain glioma.

Jiaji Zi et al.PubMed ↗Full text ↗

No numbers read from the abstract.